Project

A Phase 1/Phase 2 Study to Evaluate the Safety and Tolerability of MK-1088 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors

Ongoing - recruitment active · 2022 until 2025

Hess Dagmar, Aeschbacher Anette, Quinter Janine